Published

Serotonin 5-HT2C Receptor SignalingAnalysis Reveals Psychedelic Biased Agonism

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Figshare
Date: 2025-09-13
Source: OpenAlex
DOI: 10.1021/acschemneuro.5c00647.s001
PubMed: Unavailable

Authors

Emma M. Bonniwell (14267047)Rana Alabdali (22241286)Joseph J. Hennessey (22241289)John L. McKee (22179170)Natalie G. Cavalco (20388684)Josie C. Lammers (22241292)Ethan J. Moore (22241295)Luca Franchini (10578054)Cesare Orlandi (204175)John D. McCorvy (1416910)

Watch author

Derived topics and classifications

psilocin Depression Pharmacology Mechanism of Action Receptor Pharmacology Safety Other

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?Clinical Pharmacology & Therapeutics · 2023-10-05 Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelicsFrontiers in Psychiatry · 2024-11-06 Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimizationFrontiers in Psychiatry · 2025-04-08 Chronic pain education: past, present, and future of psychedelics for the management of chronic painPain Medicine · 2024-12-10 Psychedelics and mental health: reimagining care through science, insight, and compassion.Frontiers in pharmacology · 2025-01-01 Computationally, Electrophysiologically, and Qualitatively Characterizing Serotonergic Psychedelics; Transdiagnostic Therapeutic and Pro-Psychotic EffectsClinicalTrials.gov · 2026-07-09